한국어
English
日本語
中文(简体)
Bitrack B capsule 25 mg (Larotrectinib sulfate)
30.7mg
Hard capsule · Prescription medication
Bayer Korea Co., Ltd.
Larotrectinib sulfate is a targeted anticancer drug used in the treatment of cancers with specific genetic mutations.
MFDS ingredient code M278648
Larotrectinib sulfate is a targeted anticancer agent that targets TRK proteins. This agent is used to inhibit the abnormally activated TRK proteins caused by specific genetic mutations in cancer cells, preventing the growth of cancer cells.
Larotrectinib sulfate blocks the action of abnormally activated TRK proteins in cancer cells. This disrupts the signaling that allows cancer cells to proliferate and survive, thereby slowing or halting the progression of cancer.
Approved uses differ by product. Check each product's information for its actual use.
Larotrectinib sulfate is distinguished from other anticancer agents by its selective inhibition of TRK proteins. It is effective only in cancers with specific genetic mutations and tends to have relatively fewer side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total
30.7mg
Hard capsule · Prescription medication
Bayer Korea Co., Ltd.
122.9mg
Hard capsule · Prescription medication
Bayer Korea Co., Ltd.
2.46g
Solution · Prescription medication
Bayer Korea Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.